Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Unity Biotechnology

NASDAQ UBX
$1.63 0.15 10.14%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

23.30M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
6.95M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.22
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
15.74M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-23.32 %

Upcoming events Unity Biotechnology

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Unity Biotechnology

Stock analysis Unity Biotechnology

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.70 28.32
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.82 4.48
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.17 11.33
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.40 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-117.37 10.75

Price change Unity Biotechnology per year

2.33$ 9.78$
Min Max

Summary analysis Unity Biotechnology

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Unity Biotechnology

Revenue and net income Unity Biotechnology

All parameters

Stock news Unity Biotechnology

All news
24 April 2023 в 19:51

Unity Biotechnology Shares Fall 9% on Latest Study Results to Treat Diabetes Condition

24 April 2023 в 19:50

Unity Biotechnology Shares Fall 9% on Latest Study Results to Treat Diabetes Condition

27 March 2023 в 18:48

Unity Biotechnology Shares Plumb New Depths After Study Setback >UBX

27 March 2023 в 18:48

Unity Biotechnology Shares Plumb New Depths After Study Setback >UBX

27 March 2023 в 14:56

Unity Biotechnology Shares Slide Premarket on Wet AMD Study Setback >UBX

27 March 2023 в 14:56

Unity Biotechnology Shares Slide Premarket on Wet AMD Study Setback >UBX

1 November 2022 в 16:45

Unity Biotechnology Shares Jump on Phase 2 Study Success >UBX

1 November 2022 в 16:45

Unity Biotechnology Shares Jump on Phase 2 Study Success >UBX

18 August 2022 в 17:01

Unity Biotechnology Shares Slide After Public Offering Announcement

18 August 2022 в 17:01

Unity Biotechnology Shares Slide After Public Offering Announcement

10 November 2021 в 15:06

Unity Biotechnology upgraded to buy from neutral at Mizuho

About company Unity Biotechnology

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate include UBX1325, which is Phase I clinical trial for the treatment of age-related diseases of the eye, including age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. It is also developing UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Address:
285 East Grand Avenue, South San Francisco, CA, United States, 94080
Company name: Unity Biotechnology
Issuer ticker: UBX
ISIN: US91381U1016
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-05-03
Sector: Healthcare
Industry: Biotechnology
Site: https://www.unitybiotechnology.com

On which stock exchange are Unity Biotechnology (UBX) stocks traded?

Unity Biotechnology (UBX) stocks are traded on NASDAQ.

What is the ticker of Unity Biotechnology stocks (UBX)?

The stock ticker of Unity Biotechnology’s stocks or in other words, the code is UBX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Unity Biotechnology (UBX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Unity Biotechnology (UBX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Unity Biotechnology (UBX) stocks traded?

Unity Biotechnology (UBX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Unity Biotechnology (UBX) stocks today?

The current price of Unity Biotechnology stocks on 30.05.2024 is 1.63 dollars. per share.

What is the dynamics of Unity Biotechnology (UBX) stocks from the beginning of the year?

Unity Biotechnology (UBX) quotes have increased by -15.1% from the beginning of the year up to 1.63 dollars. per 1 stocks.

How much did Unity Biotechnology (UBX) stocks increase in may 2024?

This month Unity Biotechnology (UBX) quotes have increased by 4.49% to 1.63 dollars. per share.

How much are Unity Biotechnology (UBX) stocks worth?

Today, on October, 30.05.2024 Unity Biotechnology’s (UBX) stocks cost 1.63 dollars..

What is the market capitalization of Unity Biotechnology (UBX)?

Capitalization is the market value of Unity Biotechnology (UBX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 30.05.2024, the market capitalization of Unity Biotechnology (UBX) is estimated at about 23300783 dollars.